Stay updated with breaking news from Peter Powchik. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CAPE CANAVERAL, Fla., Nov. 08, 2023 -- Vaxxinity, Inc. , a U.S. company pioneering the development of a new class of medicines, today reported financial results for the third quarter ended...
CAPE CANAVERAL, Fla., Aug. 09, 2023 -- Vaxxinity, Inc. ; class='js-l-obf link link--blue'
By Daniella Parra Vaxxinity, Inc. (Nasdaq: VAXX) said it appointed Peter Powchik, M.D. as Executive Vice President, Global Scientific Director overseeing its scientific direction and lead development efforts. Powchik was previously Senior Vice President at Regeneron Pharmaceuticals, the company said. Additionally, Ulo Palm, M.D., will transition from Chief Medical Officer to senior advisor, it said. […]
Appointment adds Dr. Powchik’s experience in the development of marketed immunotherapeutics to Vaxxinity’s leadership team CAPE CANAVERAL, Fla., July 27,...